CenterBook Partners LP Sells 40,967 Shares of U.S. Physical Therapy, Inc. $USPH

CenterBook Partners LP cut its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 87.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,047 shares of the company’s stock after selling 40,967 shares during the quarter. CenterBook Partners LP’s holdings in U.S. Physical Therapy were worth $514,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of USPH. Cullen Frost Bankers Inc. raised its stake in shares of U.S. Physical Therapy by 171.8% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock worth $35,000 after acquiring an additional 280 shares in the last quarter. Assetmark Inc. increased its position in shares of U.S. Physical Therapy by 35.7% during the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock worth $45,000 after purchasing an additional 150 shares in the last quarter. Huntington National Bank lifted its holdings in shares of U.S. Physical Therapy by 71.9% during the 2nd quarter. Huntington National Bank now owns 667 shares of the company’s stock valued at $52,000 after purchasing an additional 279 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of U.S. Physical Therapy by 35.3% during the 3rd quarter. Blue Trust Inc. now owns 640 shares of the company’s stock valued at $54,000 after purchasing an additional 167 shares during the last quarter. Finally, Fifth Third Bancorp boosted its position in shares of U.S. Physical Therapy by 38.7% in the 3rd quarter. Fifth Third Bancorp now owns 702 shares of the company’s stock worth $60,000 after purchasing an additional 196 shares in the last quarter.

Analysts Set New Price Targets

USPH has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, January 21st. JPMorgan Chase & Co. decreased their price objective on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a research report on Monday, November 24th. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Monday, December 15th. Finally, Barrington Research reissued an “outperform” rating and set a $103.00 target price on shares of U.S. Physical Therapy in a research report on Friday. Four investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and an average price target of $105.33.

U.S. Physical Therapy Trading Down 1.6%

U.S. Physical Therapy stock opened at $85.08 on Friday. The stock has a 50-day moving average price of $83.30 and a 200 day moving average price of $82.55. The company has a market capitalization of $1.29 billion, a price-to-earnings ratio of 35.75, a price-to-earnings-growth ratio of 3.51 and a beta of 1.30. U.S. Physical Therapy, Inc. has a 52 week low of $62.77 and a 52 week high of $93.50. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.